...
首页> 外文期刊>Journal of Clinical Microbiology >Differential blocking of coagulation-activating pathways of Limulus amebocyte lysate.
【24h】

Differential blocking of coagulation-activating pathways of Limulus amebocyte lysate.

机译:am细胞溶胞产物的凝血激活途径的差异性阻断。

获取原文

摘要

The coagulation of Limulus amebocyte lysate (LAL) can be activated through two pathways, one initiated by endotoxin and the other by beta-glucans. The two pathways join at the step of activation of the proclotting enzyme. We report here that the endotoxin-activated pathway can be differentially inhibited by two methods in a Limulus enzyme-linked immunosorbent assay (ELISA), either by the combined use of dimethyl sulfoxide and polymyxin B or by a monoclonal antibody against Limulus factor C. LAL reactivities to 10 different endotoxin preparations could be inhibited by the former method by a factor of 10(4) to 10(6) and could be blocked almost totally by the latter method, irrespective of the source of endotoxin. The sensitivity of the assay was approximately 50 pg/ml both for curdlan from Alcaligenes faecalis and for laminarin from Laminaria digitata. We also found that the beta-glucan-activated pathway could be totally blocked by laminarin (> 1 microgram/ml) without affecting the endotoxin-activated pathway, allowing endotoxin to be quantitated specifically by the Limulus ELISA with a detection limit of 0.005 endotoxin unit per ml. The use of uninhibited and differentially inhibited ELISAs demonstrated that different LAL preparations showed much greater variation in assaying beta-glucans than in assaying endotoxins. The LAL reactivity of normal human plasma was found to be due to the activation of the beta-glucan pathway, but not the endotoxin pathway, of LAL.
机译:am变形细胞溶解物(LAL)的凝结可以通过两种途径激活,一种途径是由内毒素引发,另一种途径是由β-葡聚糖。这两个途径在促凝酶的活化步骤中结合。我们在这里报告,通过结合使用二甲基亚砜和多粘菌素B或抗Li因子C的单克隆抗体,Li酶联免疫吸附测定(ELISA)中的两种方法可以差异抑制内毒素激活的途径。前者的方法可以抑制10种不同内毒素制剂的反应性,其抑制因子是10(4)至10(6),而后者的方法几乎可以完全阻止后者的反应,而与内毒素的来源无关。对于粪便产碱杆菌的凝胶多糖和指状海带的laminarin而言,该测定的灵敏度均为约50 pg / ml。我们还发现,β-葡聚糖激活的途径可以被层粘连蛋白(> 1微克/毫升)完全阻断,而不会影响内毒素激活的途径,从而可以通过mulELISA定量检测内毒素,检测限为0.005内毒素单位每毫升使用未抑制和差异抑制的ELISAs表明,不同的LAL制剂在检测β-葡聚糖时显示出比在检测内毒素中更大的变化。发现正常人血浆的LAL反应性是由于LAL的β-葡聚糖途径而不是内毒素途径的激活所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号